OFIX vs TROW · rev $799.5M vs P/E 12, rev $3.76B
Orthofix Medical Inc (OFIX) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
Orthofix Medical Inc (OFIX) is a medical devices company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported OFIX revenue for 2024-12-31 was $799.5M. Net income was -$126.0M. Revenue was up 7.1% from 2023-12-31 to 2024-12-31. OFIX currently screens at market cap $438.0M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
OFIX currently screens at market cap $438.0M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the OFIX and TROW stock pages for the full models.
Not investment advice.